Innoviva (INVA) Cash from Operations (2010 - 2026)
Innoviva (INVA) posted Cash from Operations of 35282000.0 for Q1 2026, down 75.23% on a QoQ basis from 142417000.0 in Q3 2025, and down 27.43% year-over-year from 48617000.0 in Q1 2025.
Innoviva (INVA) Cash from Operations (2010 - 2026) Analysis & Trends
Innoviva's Cash from Operations history runs 17 years deep, the most recent figure standing at 35282000.0 for Q1 2026.
- Quarterly Cash from Operations fell 27.43% year-over-year to 35282000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was 270389000.0 (up 4.46% YoY) and the FY2025 annual result came in at 196930000.0, up 4.37% from the prior year.
- Cash from Operations was 35282000.0 for Q1 2026 at Innoviva, down from 142417000.0 in the prior quarter.
- Across five years, Cash from Operations topped out at 192827000.0 in Q3 2022 and bottomed at 25684000.0 in Q1 2023.
- A 5-year average of 78634076.92 and a median of 48617000.0 in 2025 frame the typical range for Cash from Operations.
- Annual changes were most pronounced in 2023 — Cash from Operations sank 73.82% — and 2024, when it jumped 44.24%.
- Innoviva's Cash from Operations stood at 192827000.0 in 2022, then slumped by 44.09% to 107808000.0 in 2023, then climbed by 20.08% to 129451000.0 in 2024, then grew by 10.02% to 142417000.0 in 2025, then sank by 75.23% to 35282000.0 in 2026.
- Business Quant data shows INVA's Cash from Operations at 35282000.0 in Q1 2026, 142417000.0 in Q3 2025, and 44073000.0 in Q2 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Operations (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | -19.59 Mn |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 201.34 Mn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | -1.53 Mn |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 1.43 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 1.08 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | -354.17 Mn |
| 10 | Innoviva | 1.57 Bn | 969.11 Mn | 75.83 Mn | 35.28 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 35.28 Mn |
| Mar 31, 2026 | 35.28 Mn |
| Sep 30, 2025 | 142.42 Mn |
| Sep 30, 2025 | 142.42 Mn |
| Jun 30, 2025 | 44.07 Mn |
| Jun 30, 2025 | 44.07 Mn |
| Mar 31, 2025 | 48.62 Mn |
| Mar 31, 2025 | 48.62 Mn |
| Sep 30, 2024 | 129.45 Mn |
| Sep 30, 2024 | 129.45 Mn |
| Jun 30, 2024 | 43.72 Mn |
| Jun 30, 2024 | 43.72 Mn |
| Mar 31, 2024 | 37.05 Mn |
| Mar 31, 2024 | 37.05 Mn |
| Sep 30, 2023 | 107.81 Mn |
| Sep 30, 2023 | 107.81 Mn |
| Jun 30, 2023 | 38.18 Mn |
| Jun 30, 2023 | 38.18 Mn |
| Mar 31, 2023 | 25.68 Mn |
| Mar 31, 2023 | 25.68 Mn |